A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
Completed · Phase 3 · Has a placebo group
Conditions studied: Esophageal Squamous Cell Carcinoma (ESCC)
In brief
The purpose of this study is to evaluate the efficacy and safety of tislelizumab as first line treatment in combination with chemotherapy in participants with advanced unresectable/metastatic esophageal squamous cell carcinoma (ESCC).
Key facts
- Study ID
- NCT03783442
- Run by
- BeiGene
- People needed
- 649
- Starts
- 2018-12-11
- Expected to finish
- 2024-08-22
- Last updated by the study team
- 2025-07-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Renovatio Clinical — The Woodlands, Texas, United States
- Coffs Harbour Base Hospital — Coffs Harbour, New South Wales, Australia
- St Vincents Hospital Melbourne — Fitzroy, Victoria, Australia
- Institut Jules Bordet — Anderlecht, Belgium
- Az Sint Jan Brugge — Bruges, Belgium
- Grand Hopital de Charleroi Site Notre Dame — Charleroi, Belgium
- UZ GENT — Ghent, Belgium
- University Hospitals Leuven — Leuven, Belgium
- Chc Montlegia — Liège, Belgium
- Anhui Provincial Hospital — Hefei, Anhui, China
- Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital — Hefei, Anhui, China
- The Second Hospital of Anhui Medical University — Hefei, Anhui, China
- Beijing Friendship Hospital, Capital Medical University — Beijing, Beijing Municipality, China
- The Fifth Medical Center of Chinese Pla General Hospital — Beijing, Beijing Municipality, China
- Beijing Cancer Hospital — Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital — Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Fujian Medical University — Fuzhou, Fujian, China
- Fujian Cancer Hospital — Fuzhou, Fujian, China
- Quanzhou First Affliated Hospital of Fujian Medical University — Quanzhou, Fujian, China
- The First Affiliated Hospital of Xiamen University — Xiamen, Fujian, China
- Zhongshan Hospital Xiamen University — Xiamen, Fujian, China
- The First Affiliated Hospital, Sun Yat Sen University — Guangzhou, Guangdong, China
- The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine — Guangzhou, Guangdong, China
- Guangdong Province Traditional Chinese Medical Hospitsal — Guangzhou, Guangdong, China
- Smilow Cancer Hospital At Yale — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.